Evaluation of plasma concentrations of homocysteine, IL-6, TNF-alpha, hs-CRP, and total antioxidant capacity in patients with end-stage renal failure

Acta Medica Iranica

Volumn 52, Issue 12, 2014, Pages 893-898

  Babaei, Mahin ^a   Dashti, Nasrin ^b   Lamei, Navid ^c   Abdi, Khosrou ^d   Nazari, Farshad ^a   Abbasian, Sepideh ^d   Gerayeshnejad, Siavash ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cardiovascular disease; End stage renal disease; Hemodialysis; Homocysteine; Interleukins

Indexed keywords

C REACTIVE PROTEIN; HOMOCYSTEINE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; ANTIOXIDANT; BIOLOGICAL MARKER; TUMOR NECROSIS FACTOR;

ADULT; ANALYTICAL RESEARCH; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; END STAGE RENAL DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OXIDATIVE STRESS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; RISK FACTOR; BLOOD; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; HEMODIALYSIS; HYPERHOMOCYSTEINEMIA; KIDNEY FAILURE, CHRONIC; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; ANTIOXIDANTS; BIOMARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; INFLAMMATION; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OXIDATIVE STRESS; RENAL DIALYSIS; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84916894401     PISSN: 00446025     EISSN: 17359694     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Van Guldener C, Kulik W, Bergar R, et al. Homocysteine and methionine metabolism in ESRD: A stable isotope study. Kidney Int 1999;56(3):1064-71.
2. van Guldener C. Homocysteine and the Kidney. Curr Drug Metab 2005;6(1):23-6.
3. Stadnyk AW. Cytokine production by epithelial cells. Faseb J 1994;8(13):1041-7.
4. Chun S, Kim SB, Min W. Total Antioxidant Capacities in Patients with End-Stage Renal Disease and Effect of Hemodialysis. Korean J Clin Pathol 2000;20:275-8.
5. Tepel M, van der Giet M, Statz M, et al. The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial. Circulation 2003;107(7):992-5.
6. Stenvinkel P, Alvestrand A. Inflammation in end-stage renal disease: sources, consequences, and therapy. Semin Dial 2002;15(5):329-37.
7. Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2004;96(19):1420-5.
8. Vester B, Rasmussen K. High-performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum. Eur J Clin Chem Clin Biochem 1991;29(9):549-54.
9. Benzie IF, Strain JJ. The ferric reducing ability of plasma(FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 1996;239(1):70-6.
10. Ueland PM, Refsum H. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. J Lab Clin Med 1989;114(5):473-501.
11. Nguyen-Khoa T, Massy ZA, De Bandt JP, et al. oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment. Naphrol Dial Transplant 2001;16(2):335-40.
12. Simmons EM, Langone A, Sezer MT, et al. Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients. Transplantation 2005;79(8):914-9.
13. Stenvinkel P, Ketteler M, Johnson RT, et al. IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly. Kidney Int 2005;67(4):1216-33.
14. Filiopoulos V, Hadjiyannakos D, Takouli L, et al. Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis. Int J Artif Organs 2009;32(12):872-82.
15. Hutchinson WL, Koenig W, Fröhlich M, et al. Immunoradiometric assay of circulating C-reactive protein: age- related values in the adult general population. Clin Chem 2000;46(7):934-8.